{
  "articles": {
    "results": [
      {
        "uri": "8672504190",
        "lang": "spa",
        "isDuplicate": false,
        "date": "2025-05-10",
        "time": "13:44:18",
        "dateTime": "2025-05-10T13:44:18Z",
        "dateTimePub": "2025-05-10T13:40:55Z",
        "dataType": "news",
        "sim": 0,
        "url": "https://www.primeraedicion.com.ar/nota/101001756/toda-la-magia-del-cosplay-con-la-edicion-de-sailor-fest-en-eldorado/",
        "title": "Toda la magia del cosplay con la edici\u00f3n de Sailor Fest en Eldorado - Primera Edici\u00f3n",
        "body": "Toda la magia del cosplay con la edici\u00f3n de Sailor Fest en Eldorado. Un encuentro que contar\u00e1 con exhibiciones, concursos, shows de K-Pop y bandas en vivo, talleres de dibujo, actuaci\u00f3n, confecci\u00f3n de trajes y maquillajes para cosplays, stands, entre otras sorpresas. De esta manera, la Capital del Trabajo celebrar\u00e1 toda la cultura del anime, el k-pop, la cultura pop, el cosplay y la cultura geek, muy esperada en la regi\u00f3n.\n\nAl ser un evento familiar con una amplia agenda de actividades e invitados, se anticipa una gran convocatoria, especialmente tras el \u00e9xito de la primera edici\u00f3n realizada el a\u00f1o pasado. El festival tem\u00e1tico es organizado por Varitas M\u00e1gicas y Mucho M\u00e1s y Dreams Producciones.\n\nEntre las principales propuestas, la Sailor Fest de Eldorado contar\u00e1 con stands comerciales y gastron\u00f3micos de Misiones y otras provincias del pa\u00eds; invitados cosplayers de Misiones, Chaco y Corrientes; concursos de cosplay, K-pop y dibujo; talleres de actuaci\u00f3n para cosplayers; maquillaje de caracterizaci\u00f3n y dibujo; zona Gamer a cargo de Armate Gaming; zona de Trading Card Games a cargo de F&F; presentaciones y actividades K-pop con la participaci\u00f3n de Juntadas K-pop; espacio de karaoke, show especial con baile de Deadpool, entrevistas en vivo y sorteos.\n\nNadia Rodr\u00edguez, creadora y organizadora del evento junto a Ismael Cabral, adelant\u00f3 que la idea es llevar a cabo dos ediciones de la Sailor Fest este a\u00f1o. La primera que ser\u00e1 este s\u00e1bado y despu\u00e9s otra en agosto. Adem\u00e1s record\u00f3 el \u00e9xito de la primera edici\u00f3n que se realiz\u00f3 el a\u00f1o pasado al que consider\u00f3 \"algo muy novedoso para la ciudad\".\n\nLos ingresos para la Sailor Fest se pueden conseguir en Eldorado (en Cherry Accesorios o Outcast Tatto); y en Puerto Iguaz\u00fa (en Friki Store o Armate Gaming). Tambi\u00e9n en contacto con la organizaci\u00f3n a trav\u00e9s del Whatsapp 3751 419238. M\u00e1s informaci\u00f3n y contactos: en instagram @sailorfest / correo electr\u00f3nico [email protected].",
        "source": {
          "uri": "primeraedicion.com.ar",
          "dataType": "news",
          "title": "Primera Edici\u00f3n"
        },
        "authors": [
          {
            "uri": "gaston_mazur@primeraedicion.com.ar",
            "name": "Gaston Mazur",
            "type": "author",
            "isAgency": false
          }
        ],
        "image": "https://www.primeraedicion.com.ar/wp-content/uploads/2025/05/15.-Cultura-1.jpg",
        "eventUri": null,
        "sentiment": null,
        "wgt": 484580658,
        "relevance": 2
      },
      {
        "uri": "8672501037",
        "lang": "zho",
        "isDuplicate": true,
        "date": "2025-05-10",
        "time": "13:44:14",
        "dateTime": "2025-05-10T13:44:14Z",
        "dateTimePub": "2025-05-10T13:40:36Z",
        "dataType": "news",
        "sim": 0,
        "url": "https://m.163.com/dy/article/JV7B63DM051188EA.html",
        "title": "\u534e\u4e3a\u5151\u73b0\u4e86\u4e94\u5e74\u524d\u7684\u9633\u8c0b_\u624b\u673a\u7f51\u6613\u7f51",
        "body": "5\u67088\u65e5\uff0c\u5728\u9e3f\u8499\u7535\u8111\u6280\u672f\u4e0e\u751f\u6001\u6c9f\u901a\u4f1a\u4e0a\uff0c\u9e3f\u8499\u64cd\u4f5c\u7cfb\u7edf\u9996\u6b21\u5728\u7535\u8111\u7aef\u4eae\u76f8\u3002\n\n\u8be5\u600e\u4e48\u8bc4\u4ef7\u8fd9\u4ef6\u4e8b\u7684\u96be\u5ea6\u5462\uff1f\u4e00\u53e5\u8bdd\u603b\u7ed3\uff1a\u4ece\u534e\u4e3a\u8fd9\u5bb6\u516c\u53f8\u6210\u7acb\u4e4b\u65e5\u7b97\u8d77\uff0c\u505a\u7684\u6240\u6709\u521b\u65b0\u5c1d\u8bd5\u634f\u5408\u5728\u4e00\u8d77\uff0c\u53ef\u80fd\u90fd\u6bd4\u4e0d\u4e0a\u8fd9\u4e00\u4ef6\u4e8b\u6709\u6311\u6218\u3002\n\n\u56e0\u4e3a\u81ea\u6253Windows\u6210\u4e3a\u901a\u7528\u64cd\u4f5c\u7cfb\u7edf\u540e\uff0c\u884c\u4e1a\u91cc\u6ca1\u6709\u51fa\u73b0\u8fc7\u4efb\u4f55\u80fd\u52a8\u6447\u5176\u5784\u65ad\u5730\u4f4d\u7684\u4ea7\u54c1\uff0c\u8fd9\u79cd\u7edd\u5bf9\u7684\u9886\u5148\u5730\u4f4d\u5c06\u5404\u7c7b\u8f6f\u786c\u4ef6\u4e0e\u81ea\u8eab\u7262\u7262\u7ed1\u5b9a\u5728\u4e00\u8d77\uff0c\u65e0\u9650\u6269\u5927\u5176\u751f\u6001\u4f18\u52bf\u3002\n\n\u5373\u4fbf\u51fa\u73b0MacOS\u8fd9\u79cd\u80fd\u62a2\u5360\u5c0f\u90e8\u5206\u5e02\u573a\u7684\u64cd\u4f5c\u7cfb\u7edf\uff0c\u4f46\u4e5f\u6ce8\u5b9a\u53ea\u80fd\u5728\u5f71\u97f3\u573a\u666f\u4e2d\u504f\u5b89\u4e00\u9685\uff0c\u90a3\u4e48\u534e\u4e3a\u80fd\u5426\u7a81\u7834Windows\u7684\u9ad8\u5899\u5462\uff1f\n\n\u5bf9\u4e8e\u5927\u4f17\u6765\u8bf4\uff0c\u534e\u4e3aPC\u5e76\u4e0d\u8ba9\u4eba\u964c\u751f\u3002\n\n\u6839\u636e\u7b2c\u4e09\u65b9\u8c03\u7814\u673a\u6784Canalys\u7684\u7edf\u8ba1\u6570\u636e\uff0c\u57282024\u5e74\u4e2d\u56fd\u5927\u9646PC\u5e02\u573a\u4e2d\uff0c\u534e\u4e3a\u4ee5430\u4e07\u53f0\u51fa\u8d27\u91cf\u62ff\u4e0b\u4e8611%\u4efd\u989d\uff0c\u4f4d\u5217\u4e2d\u56fd\u5e02\u573a\u7b2c\u4e8c\u3002\n\n\u4f5c\u4e3a\u975e\u6838\u5fc3\u4e1a\u52a1\u7684PC\uff0c\u80fd\u591f\u53d6\u5f97\u8fd9\u6837\u7684\u6210\u7ee9\uff0c\u80af\u5b9a\u662f\u591f\u7528\u7684\uff0c\u90a3\u65e2\u7136\u80fd\u57fa\u4e8eWindows\u7cfb\u7edf\u53bb\u5f00\u53d1\u4ea7\u54c1\uff0c\u4e3a\u4ec0\u4e48\u8fd8\u8981\u63a8\u52a8\u9e3f\u8499PC\u9879\u76ee\uff1f\n\n\u6838\u5fc3\u539f\u56e0\u5728\u4e8e\uff0c\u5728\u624b\u673a\u548cIoT\u8bbe\u5907\u5168\u9762\u8f6c\u7528\u9e3f\u8499\u64cd\u4f5c\u540e\uff0c\u8fd9\u4e2a\u7cfb\u7edf\u7684\u90e8\u5206\u7279\u5f81\u4e0eWindows\u662f\u65e0\u6cd5\u5339\u914d\u7684\uff0c\u6bd4\u5982\u5206\u5e03\u5f0f\u8f6f\u603b\u7ebf\u80fd\u529b\uff0c\u5b83\u80fd\u591f\u8ba9\u4e0d\u540c\u7ec8\u7aef\u8bbe\u5907\u95f4\u8fdb\u884c\u9ad8\u901f\u3001\u4f4e\u5ef6\u8fdf\u7684\u6570\u636e\u4f20\u8f93\u548c\u4efb\u52a1\u534f\u540c\u3002\n\n\u4f46\u5728\u7535\u8111\u8fd0\u884cWindows\u7cfb\u7edf\u7684\u72b6\u6001\u4e0b\uff0c\u80fd\u591f\u5f00\u53d1\u51fa\u57fa\u4e8eNFC\u6280\u672f\u6253\u9020\u7684\"\u4e00\u78b0\u4f20\"\u3001\"\u591a\u5c4f\u534f\u540c\"\u529f\u80fd\u5c31\u7b97\u662f\u6570\u636e\u4f20\u8f93\u7684\u6781\u9650\u4e86\u3002\n\n\u56e0\u6b64\uff0c\u6253\u9020\u9e3f\u8499PC\uff0c\u4e0d\u4ec5\u4ec5\u662f\u6ee1\u8db3\u4e8e\"\u8865\u9f50\u5168\u573a\u666f\u5168\u751f\u6001\"\u8fd9\u79cd\u5b8f\u89c2\u53d9\u4e8b\uff0c\u5bf9\u4e8e\u4fdd\u969c\u9e3f\u8499\u7528\u6237\u8de8\u7aef\u7684\u4f53\u9a8c\u4e00\u81f4\u6027\uff0c\u8fdb\u800c\u786e\u4fddPC\u4e1a\u52a1\u672a\u6765\u7684\u957f\u4e45\u53d1\u5c55\u4e5f\u662f\u975e\u5e38\u6709\u5fc5\u8981\u7684\u3002\n\n\u534e\u4e3a\u4e5f\u662f\u65e9\u65e9\u5730\u4e3a\u9e3f\u8499\u7535\u8111\u505a\u51fa\u4e86\u89c4\u5212\u3002\u636e\u534e\u4e3a\u65b9\u9762\u4ecb\u7ecd\uff0c\u9e3f\u8499\u7535\u8111\u7ecf\u8fc7\u4e94\u5e74\u5e03\u5c40\uff0c\u96c6\u7ed3\u8d85\u8fc71\u4e07\u540d\u9876\u5c16\u5de5\u7a0b\u5e08\uff0c\u79ef\u7d2f\u8d85\u8fc72700\u9879\u6838\u5fc3\u4e13\u5229\u3002\n\n\u5f53\u7136\uff0c\u6b63\u5982\u5f00\u5934\u63d0\u5230\u7684\uff0c\u60f3\u8981\u53d6\u4ee3Windows\u64cd\u4f5c\u7cfb\u7edf\uff0c\u96be\u5ea6\u6781\u9ad8\uff0c\u90a3\u4e48\u9e3f\u8499\u7535\u8111\u7684\u751f\u6001\u4f4d\u4f1a\u5728\u54ea\u91cc\uff1f\n\n\u4e00\u4e2a\u80fd\u591f\u770b\u5f97\u5230\u7684\u5e02\u573a\u662f\u4fe1\u521b\u4ea7\u54c1\u3002\n\n\u8fd9\u662f\u4e00\u4e2a\u8fd1\u4e9b\u5e74\u5728\u653f\u7b56\u5bfc\u5411\u4e0b\u884d\u751f\u51fa\u7684\u4ea7\u4e1a\uff0c\u6838\u5fc3\u76ee\u6807\u662f\u5b9e\u73b0\u4fe1\u606f\u6280\u672f\u7684\u81ea\u4e3b\u53ef\u63a7\uff0c\u89c4\u907f\u5916\u90e8\u5236\u88c1\u548c\u98ce\u9669\uff0c\u56e0\u6b64\u5728\u76f8\u5173\u4ea7\u54c1\u7684\u91c7\u8d2d\u4e0a\u901a\u5e38\u8981\u6c42\u8f6f\u786c\u4ef6\u5b9e\u73b0\u5168\u56fd\u4ea7\u5316\u3002\n\n\u800c\u5728\u76f8\u5173\u64cd\u4f5c\u7cfb\u7edf\u65b9\u9762\uff0c\u57fa\u672c\u5c31\u662f\u57fa\u4e8eLinux\u5185\u6838\u8fdb\u884c\u4e8c\u6b21\u5f00\u53d1\uff0c\u4e0d\u5ba2\u6c14\u5730\u8bf4\uff0c\u4f53\u9a8c\u975e\u5e38\u7cdf\u7cd5\uff0c\u5927\u591a\u5c5e\u4e8e\u582a\u582a\u80fd\u7528\u7684\u6c34\u5e73\u3002\n\n\u8fd9\u91cc\u6d89\u53ca\u5230\u7684\u4e24\u4e2a\u95ee\u9898\u662f\uff0c\u5927\u90e8\u5206\u4fe1\u521b\u4ea7\u54c1\u7684\u4ece\u4e1a\u8005\u65e2\u6ca1\u6709\u5168\u6808\u7814\u53d1\u7684\u80fd\u529b\uff0c\u4e5f\u6ca1\u6709\u8ba9\u8f6f\u4ef6\u5382\u5546\u8fdb\u884c\u9002\u914d\u7684\u53f7\u53ec\u529b\u3002\n\n\u800c\u8fd9\u4e24\u4e2a\u7ef4\u5ea6\uff0c\u6070\u597d\u662f\u534e\u4e3a\u5728\u6d88\u8d39\u7535\u5b50\u884c\u4e1a\u4e2d\uff0c\u76f8\u8f83\u4e8e\u56fd\u5185\u5176\u4ed6\u5382\u5546\uff0c\u6700\u663e\u8457\u7684\u4f18\u52bf\u3002\n\n\u5bf9\u4e8e\u653f\u4f01\u91c7\u8d2d\u6765\u8bf4\uff0c\u9e3f\u8499\u7535\u8111\u4e4b\u4e8e\u8fc7\u53bb\u7684\u4fe1\u521b\u4ea7\u54c1\uff0c\u5927\u6982\u7b97\u662f\"\u5f39\u5f13\u6362\u70ae\"\u4e86\uff0c\u5c31\u4fe1\u521b\u4ea7\u54c1\u7684\u5e02\u573a\u9700\u6c42\u6765\u770b\uff0c\u9e3f\u8499\u7535\u8111\u6ce8\u5b9a\u662f\u4e2a\"\u4e0b\u9650\u5f88\u9ad8\"\u7684\u54c1\u7c7b\u3002\n\n\u90a3\u4e48\u534e\u4e3a\u4f1a\u6ee1\u8db3\u4e8e\u4ec5\u5728\u653f\u4f01\u5e02\u573a\u63a8\u52a8\u5e02\u573a\u5417\uff1f\u864e\u55c5\u8ba4\u4e3a\uff0c\u7edd\u5bf9\u4e0d\u662f\u3002\n\n\u5728\u6c9f\u901a\u4f1a\u73b0\u573a\uff0c\u534e\u4e3a\u653e\u7f6e\u4e86\u591a\u53f0\u9e3f\u8499\u7535\u8111\u6837\u673a\u4f9b\u53c2\u4f1a\u8005\u4f53\u9a8c\uff0c\u63a5\u4e0b\u6765\u7b14\u8005\u5c06\u7ed3\u5408\u81ea\u8eab\u4f53\u9a8c\u804a\u804a\u4e3a\u4ec0\u4e48\u9e3f\u8499\u7535\u8111\u662f\u4e00\u6b21\u91ce\u5fc3\u540c\u6837\u5f88\u5927\u7684\u5c1d\u8bd5\u3002\n\n\u4f5c\u4e3a\"\u9e3f\u8499\u4e0a\u673a\"\u7684\u9996\u6b21\u5c1d\u8bd5\uff0c\u534e\u4e3a\u5c06\u5168\u65b0\u7684Matebook Pro\u4f5c\u4e3a\u9e3f\u8499\u7cfb\u7edf\u7684\u9996\u6b3e\u786c\u4ef6\u5e73\u53f0\u3002\n\n\u5728\u529e\u516c\u7b14\u8bb0\u672c\u9886\u57df\u7684\u5f00\u53d1\u4e0a\uff0c\u534e\u4e3a\u65e9\u5df2\u7089\u706b\u7eaf\u9752\uff0c\u8fd9\u53f0\u65b0\u6b3e\u7684Matebook Pro\u5ef6\u7eed\u4e86Matebook\u7cfb\u5217\u7684\u8bbe\u8ba1\u8bed\u8a00\uff0c\u4f46\u6253\u5f00\u5c4f\u5e55\u540e\uff0c\u5219\u4f1a\u53d1\u73b0\u5168\u65b0\u7684\u7528\u6237\u754c\u9762\u3002\n\n\u4ece\u684c\u9762\u56fe\u6807\u548c\u5e95\u90e8Dock\u680f\u7684\u6392\u5217\u65b9\u5f0f\u4e0a\u80fd\u591f\u770b\u51fa\uff0c\u9e3f\u8499\u7cfb\u7edf\u5728\u754c\u9762\u6574\u4f53\u5e03\u5c40\u4e0a\u4e0eWindows\u7c7b\u4f3c\uff0c\u4f46\u5728\u5c4f\u5e55\u53f3\u4fa7\uff0c\u9e3f\u8499\u4e3a\u5176\u52a0\u5165\u4e86\"\u5c0f\u7ec4\u4ef6+\u4e2a\u6027\u5316\u5361\u7247\"\u7ec4\u6210\u7684\u529f\u80fd\u533a\u57df\uff0c\u8fd9\u5728\u4e00\u5b9a\u7a0b\u5ea6\u4e0a\u7b80\u5316\u4e86\u8fc7\u53bb\u684c\u9762\u7aef\u7cfb\u7edf\u7684\u64cd\u4f5c\u5c42\u7ea7\u3002\n\n\u800c\u5982\u679c\u70b9\u5f00\u8bbe\u7f6e\u754c\u9762\uff0c\u53c8\u4f1a\u53d1\u73b0\u5b83\u4e0e\u9e3f\u8499\u5e73\u677f\u4e0a\u7684\u5e03\u5c40\u51e0\u4e4e\u5b8c\u5168\u4e00\u81f4\uff0c\u5e94\u8be5\u8bf4\uff0c\u8fd9\u4e2a\u7cfb\u7edf\u6574\u5408\u4e86Windows\u548c\u624b\u673a/\u5e73\u677f\u9e3f\u8499\u7cfb\u7edf\u4e2d\uff0c\u5404\u81ea\u6700\u5feb\u6377\u7684\u90a3\u90e8\u5206\u64cd\u4f5c\u903b\u8f91\u3002\n\n\u5728\u5b9e\u9645\u4f53\u9a8c\u4e0a\uff0c\u9e3f\u8499\u7cfb\u7edf\u65e0\u8bba\u662f\u4ea4\u4e92\u8fd8\u662f\u6d41\u7545\u5ea6\uff0c\u90fd\u5b8c\u5168\u540a\u6253\u5e02\u9762\u4e0a\u5404\u79cd\"\u9b54\u6539Linux\u7cfb\u7edf\"\u3002\n\n\u63a5\u4e0b\u6765\u518d\u8bf4\u8bf4\u534e\u4e3a\u5728\u8f6f\u786c\u4ef6\u9002\u914d\u95ee\u9898\u4e0a\u7ed9\u51fa\u7684\u89e3\u51b3\u65b9\u6848\u3002\n\n\u8fd9\u5176\u5b9e\u4e5f\u662f\u5916\u754c\u6700\u5173\u5fc3\u7684\u95ee\u9898\u3002\u8003\u8651\u5230\u9e3f\u8499\u7535\u8111\u6682\u4e0d\u652f\u6301\u4fa7\u8f7d\u5b89\u88c5\uff0c\u534e\u4e3a\u4e3a\u8fd9\u53f0\u7535\u8111\u8bbe\u8ba1\u4e86\u624b\u673a/\u5e73\u677f\u540c\u6b3e\u7684\u5e94\u7528\u5546\u5e97\u3002\u53d1\u5e03\u4f1a\u73b0\u573a\uff0c\u534e\u4e3a\u65b9\u9762\u8868\u793a\uff0c\u76ee\u524d\u5df2\u6709300\u6b3e\u878d\u5408\u751f\u6001\u5e94\u7528\u5b8c\u6210\u4e86\u9002\u914d\uff0c\u8fd8\u6709\u8d85\u8fc72000\u6b3e\u878d\u5408\u751f\u6001\u5e94\u7528\u6b63\u5728\u52a0\u901f\u9002\u914d\u3002\n\n\u5f53\u7136\uff0c\u8003\u8651\u5230Windows\u6709\u7740\u6570\u4ee5\u767e\u4e07\u8ba1\u7684\u8f6f\u4ef6\u652f\u6301\uff0c\u8fd9\u79cd\u4f53\u91cf\u4f18\u52bf\u5728\u77ed\u65f6\u95f4\u5185\u4e0d\u53ef\u80fd\u88ab\u62b9\u5e73\uff0c\u9e3f\u8499\u7684\u8f6f\u4ef6\u9002\u914d\u5de5\u4f5c\u4ecd\u7136\u4efb\u91cd\u9053\u8fdc\u3002\n\n\u4f46\u8fd8\u662f\u8981\u8bf4\u660e\u7684\u4e00\u70b9\u662f\uff0c\u534e\u4e3a\u5e76\u6ca1\u6709\u628a\u8fd9\u53f0\u7535\u8111\u5b9a\u4f4d\u4e3a\u4e00\u53f0\u4ec5\u6ee1\u8db3\u4e8e\"\u57fa\u7840\u529e\u516c\"\u7684PC\uff0c\u5373\u4fbf\u73b0\u5728\u6ca1\u6709\u6b63\u5f0f\u53d1\u5e03\uff0c\u4f46\u534e\u4e3a\u62c9\u7740\u8f6f\u4ef6\u5382\u5546\u4e00\u8d77\uff0c\u5b8c\u6210\u4e86\u5236\u56fe\u3001\u526a\u8f91\u3001\u56fe\u50cf\u5904\u7406\u7b49\u8f6f\u4ef6\u7684\u9002\u914d\u5de5\u4f5c\u3002\n\n\u5728\u8f6f\u4ef6\u9002\u914d\u4e4b\u5916\uff0c\u534e\u4e3a\u4e5f\u6ca1\u6709\u843d\u4e0b\u786c\u4ef6\u751f\u6001\u7684\u9002\u914d\u3002\u4e0d\u540c\u4e8e\u667a\u80fd\u624b\u673a\u8fd9\u7c7b\u7ec8\u7aef\uff0cPC\u5bf9\u4e8e\u952e\u9f20\u3001\u6253\u5370\u673a\u3001\u6295\u5f71\u4eea\u7b49\u8fd9\u7c7b\u786c\u4ef6\u8bbe\u5907\u7684\u94fe\u63a5\u662f\u6709\u5f3a\u9700\u6c42\u7684\uff0c\u534e\u4e3a\u4e5f\u5728\u5e94\u7528\u5e02\u573a\u4e2d\u5355\u72ec\u5217\u51fa\u4e86\u4e00\u4e2a\u4e13\u533a\uff0c\u4ee5\u4e3a\u7528\u6237\u63d0\u4f9b\u4e0d\u540c\u54c1\u724c\u7684\u9a71\u52a8\u7a0b\u5e8f\u3002\n\n\u56e0\u6b64\uff0c\u7b14\u8005\u8ba4\u4e3a\uff0c\u8fd9\u7edd\u4e0d\u4f1a\u662f\u4e00\u6b3e\u4ec5\u6ee1\u8db3\u4e8e\"\u4fe1\u521b\u5e02\u573a\"\u7684\u4ea7\u54c1\uff0c\u534e\u4e3a\u5bf9\u9e3f\u8499\u7535\u8111\u7684\u5b9a\u4f4d\uff0c\u4e00\u5b9a\u662f\u53d6\u4ee3Windows\uff0c\u672a\u6765\u9010\u6b65\u6210\u4e3a\u65d7\u4e0bPC\u4ea7\u54c1\u51fa\u8d27\u7684\u652f\u6491\u70b9\u3002\n\n\u8f6f\u786c\u4ef6\u7684\u9002\u914d\u5de5\u4f5c\uff0c\u8bf4\u5230\u5e95\u5176\u5b9e\u4e5f\u662f\u5728\u8865\u5145\u81ea\u8eab\u7684\"\u77ed\u677f\"\uff0c\u90a3\u4e48\u9e3f\u8499\u7cfb\u7edf\u4f1a\u6709\u4ec0\u4e48\"\u957f\u677f\"\u5417\uff1f\n\n\u76ee\u524d\u80fd\u591f\u770b\u5230\u7684\uff0c\u9e3f\u8499\u7684\u539f\u751fAI\u529f\u80fd\u5f88\u53ef\u80fd\u4f1a\u6210\u4e3a\u4e00\u4e2a\u5173\u952e\u7834\u5c40\u70b9\u3002\n\n\u8fd9\u5012\u4e0d\u662f\u56e0\u4e3a\u9e3f\u8499\u5728AI\u529f\u80fd\u4e0a\u6709\u4ec0\u4e48\u5f97\u5929\u72ec\u539a\u7684\u4f18\u52bf\uff0c\u800c\u662f\u73b0\u5728\u7684Wiondws\u7cfb\u7edf\u5728\u4e0eAI\u7684\u9002\u914d\u4e0a\uff0c\u5df2\u7ecf\u662f\u53d1\u529b\u4e0d\u4ece\u5fc3\u3002\n\n\u6211\u4eec\u5927\u5bb6\u90fd\u77e5\u9053\uff0cWindows\u7cfb\u7edf\u5347\u7ea7\u7684\u8fc7\u7a0b\u4e2d\uff0c\u5f00\u53d1\u4eba\u5458\u4f1a\u4e3a\u5176\u5927\u91cf\u52a0\u5165\"\u8865\u4e01\u5f0f\u4ee3\u7801\"\u3002\u8fd9\u4e48\u505a\u7684\u597d\u5904\u662f\u80fd\u591f\u5feb\u901f\u54cd\u5e94\u5e02\u573a\u9700\u6c42\uff0c\u4f46\u95ee\u9898\u662f\u957f\u6b64\u4ee5\u5f80\uff0c\u7cfb\u7edf\u672c\u8eab\u6108\u53d1\u81c3\u80bf\u3002\n\n\u8fd9\u4e9b\u6df7\u4e71\u7684\u4ee3\u7801\u5982\u540c\u7f20\u7ed5\u7684\u7ebf\u56e2\u4e00\u6837\uff0c\u8ba9AI\u529f\u80fd\u7684\u5d4c\u5165\u53d8\u5f97\u4e3e\u6b65\u7ef4\u8270\u3002\u5373\u4fbf\u662f\u52a0\u5165\u4e00\u4e2a\u7b80\u5355\u7684\u667a\u80fd\u641c\u7d22\u529f\u80fd\uff0c\u5f00\u53d1\u4eba\u5458\u90fd\u4e0d\u5f97\u4e0d\u68b3\u7406\u5404\u4e2a\u6a21\u5757\u95f4\u9519\u7efc\u590d\u6742\u7684\u8c03\u7528\u5173\u7cfb\uff0c\u624d\u80fd\u786e\u4fdd\u65b0\u529f\u80fd\u4e0d\u4f1a\u7834\u574f\u539f\u6709\u7cfb\u7edf\u7684\u7a33\u5b9a\u6027\u3002\n\n\u53e6\u5916\uff0cWindows\u7cfb\u7edf\u4e2d\u7684\u4e00\u4e9b\"\u53e4\u8001\u673a\u5236\"\uff0c\u6bd4\u5982\u5185\u5b58\u7ba1\u7406\u3001\u56fe\u50cf\u754c\u9762\u3001\u7cfb\u7edf\u670d\u52a1\u7b49\uff0c\u5df2\u7ecf\u4e0eAI\u52a8\u6001\u3001\u9ad8\u6548\u3001\u5e76\u884c\u7684\u9700\u6c42\u5b58\u5728\"\u5929\u7136\u76f8\u6096\"\u7684\u60c5\u51b5\u3002\n\n\u56e0\u6b64\uff0c\u65b0\u751f\u7684\u9e3f\u8499\u7cfb\u7edf\u5728AI\u529f\u80fd\u7684\u5185\u5d4c\u4e0a\u662f\u5b8c\u5168\u5177\u5907\u540e\u53d1\u4f18\u52bf\u7684\u3002\n\n\u90a3\u4e48\u9e3f\u8499\u7535\u8111\u4e0a\u7684AI\u529f\u80fd\uff0c\u5728\u5b9e\u9645\u4f53\u9a8c\u4e0a\u5982\u4f55\u5462\uff1f\n\n\u8fd9\u91cc\u4ee5\u5c0f\u827a\u4e0a\u7684\"\u8bc6\u56fe\u5bf9\u8bdd\"\u529f\u80fd\u4e3a\u4f8b\uff0c\u7b14\u8005\u5728\u7535\u8111\u4e0a\u7528B\u7ad9\u64ad\u653e\u4e86\"\u864e\u55c5\u89c6\u9891\"\u4e8e4\u670815\u65e5\u4e0a\u4f20\u7684\u89c6\u9891\u300a120\u79cd\u6c2f\u96f7\u4ed6\u5b9a\u5230\u5e95\u662f\u548b\u9020\u51fa\u6765\u7684\uff1f\u300b\uff0c\u968f\u673a\u6682\u5b9a\u5e76\u5708\u9009\u6574\u4e2a\u64ad\u653e\u754c\u9762\uff0c\u8ba9\u5c0f\u827a\u603b\u7ed3\u8fd9\u4e00\u5e27\u7684\u753b\u9762\u4fe1\u606f\u3002\n\n\u80fd\u591f\u770b\u5230\uff0c\u5c0f\u827a\u9996\u5148\u7b5b\u9664\u4e86\u4e0e\u89c6\u9891\u65e0\u5173\u7684\u6587\u5b57\u4fe1\u606f\uff0c\u6bd4\u5982B\u7ad9\u53f3\u4fa7\u7684\u63a8\u8350\u680f\uff0c\u540c\u65f6\u51c6\u786e\u5730\u63d0\u53d6\u51fa\u4e24\u6b3e\u4eff\u5236\u836f\u7684\u914d\u65b9\u5bf9\u6bd4\u3002\u6709\u8da3\u7684\u662f\uff0c\u5c0f\u827a\u8fd8\u5bf9\u89c6\u9891\u4e0a\u65b9\u7684\u5f39\u5e55\u5355\u72ec\u5217\u51fa\uff0c\u5e76\u5206\u6790\u51fa\u8fd9\u53e5\u8bdd\u53ef\u80fd\u8868\u8fbe\u7684\u610f\u601d\u3002\n\n\u503c\u5f97\u4e00\u63d0\u7684\u662f\uff0c\u5728\u9e3f\u8499\u7535\u8111\u7684AI\u90e8\u7f72\u4e0a\uff0c\u534e\u4e3a\u9009\u62e9\u4e86\"\u7aef\u4e91\u7ed3\u5408\"\u7684\u7b56\u7565\uff0c\u5373\u5c06\u76d8\u53e4\u5927\u6a21\u578b\u4e0eDeepSeek\u7b49\u7b2c\u4e09\u65b9\u5927\u6a21\u578b\u5728\u4e91\u4fa7\u878d\u5408\u90e8\u7f72\uff0c\u540c\u65f6\u901a\u8fc7\u8f7b\u91cf\u5316\u8bbe\u8ba1\u5728\u672c\u5730\u4e5f\u8fdb\u884c\u90e8\u7f72\uff0c\u8fd9\u8ba9\u9e3f\u8499\u7535\u8111\u7684\u6838\u5fc3AI\u529f\u80fd\u65e0\u9700\u8054\u7f51\u4e5f\u53ef\u4ee5\u4f7f\u7528\u3002\n\n\u603b\u4f53\u800c\u8a00\uff0c\u4f5c\u4e3a\"\u9e3f\u8499\u7535\u8111\"\u8fd9\u4e2a\u6982\u5ff5\u7684\u9996\u6b21\u5c1d\u8bd5\uff0c\u534e\u4e3a\u4e3a\u5176\u5185\u5d4c\u7684AI\u529f\u80fd\u53ca\u5e94\u7528\uff0c\u7684\u786e\u8981\u9ad8\u4e8e\u9884\u671f\u3002\n\n\u9e3f\u8499\u7535\u8111\u80fd\u591f\u91ca\u653e\u591a\u5c11\u5e02\u573a\uff0c\u8fd9\u4e2a\u95ee\u9898\u73b0\u5728\u53ef\u80fd\u9700\u8981\u5206\u7c7b\u8ba8\u8bba\u3002\n\n\u6b63\u5982\u524d\u6587\u6240\u63d0\u5230\u7684\uff0c\u5728\u653f\u4f01\u5e02\u573a\uff0c\u56e0\u4e3a\u6709\"\u4fe1\u521b\u4ea7\u54c1\"\u8fd9\u4e2a\u5f3a\u9700\u6c42\uff0c\u4ee5\u53ca\u534e\u4e3a\u81ea\u8eab\u5728\u8f6f\u786c\u4ef6\u534f\u540c\u7814\u53d1\u548c\u751f\u6001\u9886\u5bfc\u4f4d\u7684\u4f18\u52bf\uff0c\u534e\u4e3a\u672a\u6765\u5c06\u51ed\u501f\u9e3f\u8499\u7535\u8111\u7edf\u4e00\u8fd9\u4e2a\u5e02\u573a\uff0c\u6ca1\u6709\u4efb\u4f55\u60ac\u5ff5\u3002\n\n\u4f46\u4ece\u534e\u4e3a\u7684\u5e03\u5c40\u6765\u770b\uff0c\u9e3f\u8499\u7535\u8111\u662f\u8981\u5728\"\u6d88\u8d39\u7ea7\u5e02\u573a\"\u62fc\u523a\u5200\u7684\uff0c\u90a3\u4e48\u8be5\u7cfb\u5217\u4ea7\u54c1\u80fd\u652f\u6491\u534e\u4e3a\u7684\u91ce\u5fc3\u5417\uff1f\n\n\u7b14\u8005\u8ba4\u4e3a\uff0c\u77ed\u671f\u5185\u60f3\u8981\u4e0eWindows\u6b63\u9762\u5bf9\u6297\u975e\u5e38\u56f0\u96be\uff0c\u8fd9\u4e2a\u77ed\u671f\uff0c\u53ef\u80fd\u662f\u4ee5\u4e94\u5e74\u3001\u4e43\u81f3\u5341\u5e74\u4e3a\u5355\u4f4d\u7684\u3002\n\n\u9664\u4e86\u53cd\u590d\u8c08\u5230\u7684\"\u8f6f\u786c\u4ef6\u9002\u914d\u95ee\u9898\"\u5916\uff0c\u8fd8\u6709\u5c31\u662f\u7535\u8111\u64cd\u4f5c\u7684\u7814\u53d1\uff0c\u672c\u8eab\u662f\u4e00\u9879\"\u9700\u6c42\u6781\u4e3a\u53d1\u6563\"\u7684\u5de5\u7a0b\u3002\n\n\u4ec0\u4e48\u662f\u9700\u6c42\u53d1\u6563\uff1f\n\n\u4e3e\u4e00\u4e2a\u4f8b\u5b50\uff0c\u82f1\u4f1f\u8fbe\u7684\u9ad8\u6027\u80fd\u8ba1\u7b97\u5361\u5411\u4e2d\u56fd\u5927\u9646\u65ad\u4f9b\u540e\uff0c\u6025\u9700\u56fd\u4ea7\u65b9\u6848\u6765\u586b\u8865\u5e02\u573a\uff0c\u56fd\u4ea7\u65b9\u6848\u6027\u80fd\u4f18\u5f02\uff0c\u4f46\u5361\u95f4\u4e92\u8054\u4e0a\u8f83\u82f1\u4f1f\u8fbe\u7684NVLink\u76f8\u6bd4\u8fd8\u6709\u5dee\u8ddd\uff0c\u5b83\u7684\u5f00\u53d1\u90e8\u95e8\u5c31\u6709\u4e00\u4e2a\u5f88\u660e\u786e\u7684\u76ee\u6807\uff1a\u63d0\u9ad8\u5361\u95f4\u4e92\u8054\u5e26\u5bbd\uff0c\u5e76\u57fa\u4e8e\u6b64\u5f00\u53d1\u65b0\u7684\u4e92\u8054\u67b6\u6784\u3001\u96c6\u5408\u901a\u4fe1\u5e93\u7b49\u7b49\u3002\n\n\u4f46\u7535\u8111\u7684\u5e94\u7528\u573a\u666f\u592a\u8fc7\u590d\u6742\uff0c\u5373\u4fbf\u662f\u540c\u4e00\u573a\u666f\u4e0b\uff0c\u5728\u4e0d\u540c\u5e94\u7528\u4e2d\u7684\u9700\u6c42\u4e5f\u4e94\u82b1\u516b\u95e8\uff0c\u6bd4\u5982\u4e3a\u8f6f\u4ef6\u63d0\u4f9b\u7cfb\u7edf\u5b89\u5168\u8bbe\u8ba1\u65f6\uff0c\u662f\u5426\u9700\u8981\u5b9e\u65f6\u68c0\u6d4b\uff0c\u4ec0\u4e48\u65f6\u5019\u9884\u8b66\u673a\u5236\u4ecb\u5165\uff0c\u662f\u5426\u690d\u5165\u52a0\u5bc6\u7b97\u6cd5......\u8fd9\u79cd\u9700\u6c42\u7684\u53d1\u6563\u6027\uff0c\u6ce8\u5b9a\u7535\u8111\u64cd\u4f5c\u7cfb\u7edf\u7684\u5f00\u53d1\u4f1a\u662f\u4e2a\u975e\u5e38\u6f2b\u957f\u7684\u8fc7\u7a0b\u3002\n\n\u8fd8\u6709\u4e00\u4e2a\u65e0\u6cd5\u5ffd\u89c6\u7684\u95ee\u9898\u662f\u7528\u6237\u7684\u4f7f\u7528\u4e60\u60ef\u3002Windows\u7cfb\u7edf\u5386\u7ecf\u4e86\u6570\u5341\u5e74\u53d1\u5c55\uff0c\u5176\u64cd\u4f5c\u903b\u8f91\u3001\u5feb\u6377\u952e\u8bbe\u7f6e\u3001\u6587\u4ef6\u7ba1\u7406\u4f53\u7cfb\u7b49\u5df2\u6210\u4e3a\u5927\u4f17\u5fc3\u4e2d\u7684\u6807\u51c6\u8303\u5f0f\uff0c\u751a\u81f3\u662f\u67d0\u79cd\u808c\u8089\u8bb0\u5fc6\u3002\n\n\u9e3f\u8499\u7535\u8111\u60f3\u8981\u5728\u77ed\u65f6\u95f4\u5185\u626d\u8f6c\u7528\u6237\u7684\u4f7f\u7528\u4e60\u60ef\uff0c\u7edd\u975e\u6613\u4e8b\u3002\n\n\u4e0d\u8fc7\uff0c\u53ea\u8981\u8fc8\u51fa\u81ea\u7814\u64cd\u4f5c\u7cfb\u7edf\u8fd9\u8270\u96be\u7684\u4e00\u6b65\uff0c\u957f\u671f\u770b\u9e3f\u8499\u7535\u8111\u8fd8\u662f\u975e\u5e38\u5177\u6709\u60f3\u8c61\u7a7a\u95f4\u7684\u3002\n\n\u6bd5\u7adf\uff0c\u9e3f\u8499\u64cd\u4f5c\u7cfb\u7edf\u81ea2019\u5e74\u4e0a\u5e02\u8d77\uff0c\u57285\u5e74\u7684\u65f6\u95f4\u5185\uff0c\u5176\u667a\u80fd\u624b\u673a\u548cIoT\u8bbe\u5907\u7684\u7d2f\u8ba1\u7528\u6237\u8fbe\u52309\u4ebf\uff0c\u6709\u7740\u8fd9\u6837\u7684\u7528\u6237\u57fa\u7840\uff0c\"\u9e3f\u8499\u7535\u8111\"\u7684\u6982\u5ff5\u672a\u6765\u6709\u6781\u5927\u6982\u7387\u80fd\u591f\u88ab\u5151\u73b0\u3002\n\n\u6ce8\uff1a\u864e\u55c5App\u539f\u751f\u9e3f\u8499\u7248\u73b0\u5df2\u4e0a\u67b6\uff0c\u6b22\u8fce\u5b89\u88c5HarmonyOSNEXT\u7cfb\u7edf\u7684\u55c5\u53cb\u4eec\u5728\u5e94\u7528\u5e02\u573a\u641c\u7d22\u300c\u864e\u55c5\u300d\u4e0b\u8f7d\u4f53\u9a8c\u3002\n\n\u672c\u6587\u6765\u81ea\u864e\u55c5\uff0c\u539f\u6587\u94fe\u63a5\uff1ahttps://www.huxiu.com/article/4331750.html?f=wyxwapp",
        "source": {
          "uri": "m.163.com",
          "dataType": "news",
          "title": "m.163.com"
        },
        "authors": [],
        "image": "https://nimg.ws.126.net/?url=http%3A%2F%2Fdingyue.ws.126.net%2F2025%2F0510%2Fcae47295j00sw0nw0008yd002bc01awg.jpg&thumbnail=750x2147483647&quality=75&type=jpg",
        "eventUri": null,
        "sentiment": null,
        "wgt": 484580654,
        "relevance": 1
      },
      {
        "uri": "8672501252",
        "lang": "zho",
        "isDuplicate": false,
        "date": "2025-05-10",
        "time": "13:43:37",
        "dateTime": "2025-05-10T13:43:37Z",
        "dateTimePub": "2025-05-10T13:40:39Z",
        "dataType": "news",
        "sim": 0.658823549747467,
        "url": "https://m.163.com/dy/article/JV7MJMHE055616WO.html",
        "title": "\u88ab\u5df4\u94c1\u6253\u5f97\u6ca1\u813e\u6c14\uff0c\u5370\u5a92\u5355\u65b9\u9762\u5ba3\u5e03\uff1a\u51fb\u843d\u4e09\u67b6\u5df4\u57fa\u65af\u5766\u6218\u673a_\u624b\u673a\u7f51\u6613\u7f51",
        "body": "\u88ab\u5df4\u94c1\u6253\u5f97\u6ca1\u813e\u6c14\uff0c\u5370\u5a92\u5355\u65b9\u9762\u5ba3\u5e03\uff1a\u51fb\u843d\u4e09\u67b6\u5df4\u57fa\u65af\u5766\u6218\u673a\n\n2023\u5e745\u67087\u65e5\u665a\uff0c\u5370\u5df4\u7a7a\u519b\u5728\u8fb9\u5883\u5730\u533a\u7206\u53d1\u4e86\u4e00\u573a\u89c4\u6a21\u7a7a\u524d\u7684\u7a7a\u6218\u3002\u5df4\u57fa\u65af\u5766\u5b98\u65b9\u5ba3\u5e03\u51fb\u843d\u4e94\u67b6\u5370\u5ea6\u6218\u673a\uff0c\u5305\u62ec\u4e09\u67b6\"\u9635\u98ce\"\u3001\u4e00\u67b6\u82cf-30\u548c\u4e00\u67b6\u7c73\u683c-29\uff0c\u5e76\u63d0\u4f9b\u4e86\u6b8b\u9ab8\u7167\u7247\u4f5c\u4e3a\u8bc1\u636e\u3002\u5370\u5ea6\u65b9\u9762\u5219\u58f0\u79f0\u51fb\u843d\u4e86\u4e09\u67b6\u5df4\u57fa\u65af\u5766\u6218\u673a\uff0c\u5176\u4e2d\u5305\u62ec\u4e00\u67b6F-16\u548c\u4e24\u67b6\u67ad\u9f99\uff0c\u4f46\u5176\u8bf4\u6cd5\u7f3a\u4e4f\u53ef\u9760\u8bc1\u636e\u652f\u6301\uff0c\u5f15\u53d1\u56fd\u9645\u5a92\u4f53\u7684\u8d28\u7591\u3002\n\n\u8fd9\u573a\u7a7a\u6218\u4e0d\u4ec5\u662f\u4e24\u56fd\u519b\u4e8b\u6280\u672f\u7684\u8f83\u91cf\uff0c\u4e5f\u6210\u4e3a\u8206\u8bba\u6218\u7684\u7126\u70b9\u3002\u53cc\u65b9\u6218\u679c\u4e3a\u4f55\u5b58\u5728\u5de8\u5927\u5206\u6b67\uff1f\u73b0\u4ee3\u7a7a\u6218\u7684\u6280\u672f\u4e0e\u6218\u672f\u5982\u4f55\u5f71\u54cd\u7ed3\u679c\uff1f\n\n\u5df4\u57fa\u65af\u5766\u6218\u679c\uff1a\u6b7c-10CE\u4e0ePL-15E\u5bfc\u5f39\u7684\u4f18\u52bf\n\n\u5df4\u57fa\u65af\u5766\u65b9\u9762\u5728\u7a7a\u6218\u7ed3\u675f\u540e\u8fc5\u901f\u516c\u5e03\u4e86\u6218\u679c\uff0c\u5e76\u63d0\u4f9b\u4e86\u5305\u62ec\"\u9635\u98ce\"\u6218\u673a\u53d1\u52a8\u673a\u6b8b\u9ab8\u548cPL-15E\u5bfc\u5f39\u788e\u7247\u5728\u5185\u7684\u8bc1\u636e\u3002\u8fd9\u4e9b\u8bc1\u636e\u4e0d\u4ec5\u8ba9\u5df4\u65b9\u7684\u58f0\u660e\u66f4\u5177\u8bf4\u670d\u529b\uff0c\u4e5f\u5f97\u5230\u4e86\u7b2c\u4e09\u65b9\u7684\u90e8\u5206\u8bc1\u5b9e\u3002\u6cd5\u56fd\u60c5\u62a5\u5b98\u5458\u627f\u8ba4\u4e00\u67b6\"\u9635\u98ce\"\u6218\u673a\u88ab\u51fb\u843d\uff0c\u7f8e\u56fd\u5a92\u4f53CNN\u4e5f\u63f4\u5f15\u6d88\u606f\u79f0\u5df4\u57fa\u65af\u5766\u51fb\u843d\u4e86\u4e00\u67b6\u5370\u5ea6\u6218\u673a\u3002\u5df4\u57fa\u65af\u5766\u7a7a\u519b\u6b64\u6b21\u4f7f\u7528\u7684\u4e3b\u529b\u6218\u673a\u662f\u6b7c-10CE\u3002\u8fd9\u6b3e\u7531\u4e2d\u56fd\u5236\u9020\u7684\u7b2c\u56db\u4ee3\u6218\u673a\u914d\u5907\u4e86\u5148\u8fdb\u7684\u6709\u6e90\u76f8\u63a7\u9635\u96f7\u8fbe\uff08AESA\uff09\u548cPL-15E\u8fdc\u7a0b\u7a7a\u7a7a\u5bfc\u5f39\u3002PL-15E\u5bfc\u5f39\u5c04\u7a0b\u8d85\u8fc7200\u516c\u91cc\uff0c\u5177\u5907\u8d85\u89c6\u8ddd\u6253\u51fb\u80fd\u529b\uff0c\u662f\u73b0\u4ee3\u7a7a\u6218\u4e2d\u7684\u4e00\u5927\u5229\u5668\u3002\u5df4\u65b9\u79f0\uff0c\u6b63\u662f\u6b7c-10CE\u4e0ePL-15E\u5bfc\u5f39\u7684\u5f3a\u5927\u7ec4\u5408\uff0c\u5e2e\u52a9\u5176\u5728\u7a7a\u6218\u4e2d\u53d6\u5f97\u538b\u5012\u6027\u80dc\u5229\u3002\n\n\u5370\u5ea6\u6218\u679c\u5b58\u7591\uff1a\u7f3a\u4e4f\u8bc1\u636e\u4e0e\u6280\u672f\u903b\u8f91\u77db\u76fe\n\n\u76f8\u6bd4\u5df4\u57fa\u65af\u5766\u7684\u8fc5\u901f\u58f0\u660e\uff0c\u5370\u5ea6\u7684\u6218\u679c\u516c\u5e03\u663e\u5f97\u59d7\u59d7\u6765\u8fdf\u3002\u4e24\u5929\u540e\uff0c\u5370\u5ea6\u5a92\u4f53\u300a\u4eca\u65e5\u5370\u5ea6\u300b\u548c\u300a\u65b0\u5fb7\u91cc\u7535\u89c6\u53f0\u300b\u58f0\u79f0\u5370\u5ea6\u7a7a\u519b\u51fb\u843d\u4e86\u4e09\u67b6\u5df4\u57fa\u65af\u5766\u6218\u673a\uff0c\u5305\u62ec\u4e00\u67b6F-16\u548c\u4e24\u67b6\u67ad\u9f99\u3002\u7136\u800c\uff0c\u8fd9\u4e00\u8bf4\u6cd5\u5b58\u5728\u660e\u663e\u6f0f\u6d1e\uff1a\n\n\u5370\u5ea6\u65b9\u9762\u672a\u63d0\u4f9b\u4efb\u4f55\u5173\u4e8eF-16\u548c\u67ad\u9f99\u88ab\u51fb\u843d\u7684\u7167\u7247\u6216\u89c6\u9891\u3002\u5df4\u57fa\u65af\u5766\u5219\u660e\u786e\u8868\u793a\uff0c\u5176F-16\u6218\u673a\u672a\u53c2\u4e0e\u6b64\u6b21\u7a7a\u6218\uff0c\u56e0\u4e3a\u7f8e\u56fd\u5bf9\u5df4\u57fa\u65af\u5766F-16\u7684\u4f7f\u7528\u6709\u4e25\u683c\u9650\u5236\u3002\n\n\u5370\u5ea6\u5a92\u4f53\u79f0\u4f7f\u7528\u5730\u7a7a\u5bfc\u5f39\u51fb\u843d\u5df4\u57fa\u65af\u5766\u6218\u673a\uff0c\u4f46\u5176\u516c\u5e03\u7684\u753b\u9762\u66f4\u50cf\u662f\u9ad8\u5c04\u70ae\u6216\u9ad8\u5c04\u673a\u67aa\u62e6\u622a\u4f4e\u7a7a\u76ee\u6807\u3002\u8fd9\u4e0e\u73b0\u4ee3\u7a7a\u6218\u4e2d\u9ad8\u7a7a\u9ad8\u901f\u4ea4\u6218\u7684\u7279\u70b9\u4e0d\u7b26\u3002\n\n\u5df4\u57fa\u65af\u5766\u5728\u7a7a\u6218\u7ed3\u675f\u540e\u7acb\u5373\u516c\u5e03\u6218\u679c\uff0c\u800c\u5370\u5ea6\u5374\u5728\u4e24\u5929\u540e\u624d\u58f0\u79f0\u53d6\u5f97\u6218\u679c\u3002\u8fd9\u79cd\u5ef6\u8fdf\u96be\u4ee5\u4e0e\u73b0\u4ee3\u7a7a\u6218\u4e2d\u5b9e\u65f6\u4fe1\u606f\u4f20\u64ad\u7684\u89c4\u5f8b\u76f8\u5339\u914d\u3002\n\n\u56fd\u9645\u5a92\u4f53\u5bf9\u6b64\u8fdb\u884c\u4e86\u4e25\u5389\u6279\u8bc4\u3002\u7f8e\u56fd\u5a92\u4f53\u76f4\u8a00\uff0c\u5370\u5ea6\u7684\u62a5\u9053\"\u5145\u6ee1\u6c11\u65cf\u4e3b\u4e49\u8272\u5f69\"\uff0c\u7f3a\u4e4f\u4e8b\u5b9e\u4f9d\u636e\u3002\n\n\u6280\u672f\u4e0e\u6218\u672f\uff1a\u73b0\u4ee3\u7a7a\u6218\u7684\u51b3\u80dc\u56e0\u7d20\n\n\u6b64\u6b21\u7a7a\u6218\u7684\u7ed3\u679c\u51f8\u663e\u4e86\u73b0\u4ee3\u7a7a\u6218\u6280\u672f\u4e0e\u6218\u672f\u7684\u91cd\u8981\u6027\u3002\u5df4\u57fa\u65af\u5766\u7684\u6b7c-10CE\u6218\u673a\u5728\u96f7\u8fbe\u7cfb\u7edf\u3001\u5bfc\u5f39\u6027\u80fd\u548c\u673a\u52a8\u80fd\u529b\u4e0a\u5168\u9762\u9886\u5148\u5370\u5ea6\u7684\u82cf-30\u548c\u7c73\u683c-29\u3002PL-15E\u5bfc\u5f39\u7684\u8fdc\u7a0b\u6253\u51fb\u80fd\u529b\u8ba9\u5df4\u65b9\u5728\u8d85\u89c6\u8ddd\u7a7a\u6218\u4e2d\u5360\u636e\u4e3b\u52a8\u3002\n\n\u6b64\u5916\uff0c\u5df4\u57fa\u65af\u5766\u5728\u6218\u672f\u90e8\u7f72\u4e0a\u4e5f\u66f4\u4e3a\u7cbe\u786e\u3002\u901a\u8fc7\u9884\u8b66\u673a\u548c\u7535\u5b50\u6218\u7cfb\u7edf\u7684\u914d\u5408\uff0c\u5df4\u65b9\u5b9e\u73b0\u4e86\u7cbe\u51c6\u6253\u51fb\u3002\u800c\u5370\u5ea6\u867d\u7136\u51fa\u52a8\u4e8670\u591a\u67b6\u6218\u673a\uff0c\u5374\u56e0\u6218\u672f\u6307\u6325\u6df7\u4e71\u5bfc\u81f4\u5175\u529b\u4f18\u52bf\u672a\u80fd\u8f6c\u5316\u4e3a\u6218\u679c\u3002\n\n\u5a92\u4f53\u4e0e\u8206\u8bba\uff1a\u6c11\u65cf\u4e3b\u4e49\u4e0e\u4e8b\u5b9e\u7684\u8f83\u91cf\n\n\u5370\u5df4\u7a7a\u6218\u4e0d\u4ec5\u662f\u519b\u4e8b\u5bf9\u6297\uff0c\u4e5f\u662f\u8206\u8bba\u6218\u7684\u5ef6\u7eed\u3002\u5370\u5ea6\u5a92\u4f53\u7684\u62a5\u9053\u88ab\u6279\u8bc4\u4e3a\"\u6c11\u65cf\u4e3b\u4e49\u5ba3\u4f20\"\uff0c\u8bd5\u56fe\u901a\u8fc7\u865a\u5047\u6218\u679c\u633d\u56de\u56fd\u5185\u6c11\u4f17\u7684\u4fe1\u5fc3\u3002\u800c\u5df4\u57fa\u65af\u5766\u5219\u5229\u7528\u771f\u5b9e\u6218\u679c\u8fdb\u884c\u5ba3\u4f20\uff0c\u63d0\u5347\u4e86\u5176\u56fd\u9645\u5f62\u8c61\u3002\n\n\u56fd\u9645\u5a92\u4f53\u5728\u6b64\u6b21\u4e8b\u4ef6\u4e2d\u626e\u6f14\u4e86\u91cd\u8981\u89d2\u8272\u3002\u6cd5\u56fd\u548c\u7f8e\u56fd\u7684\u90e8\u5206\u8bc1\u5b9e\uff0c\u8ba9\u5df4\u57fa\u65af\u5766\u7684\u8bf4\u6cd5\u66f4\u5177\u53ef\u4fe1\u6027\u3002\u800c\u5370\u5ea6\u7684\u8fdf\u7f13\u58f0\u660e\u548c\u7f3a\u4e4f\u8bc1\u636e\u7684\u62a5\u9053\uff0c\u5219\u663e\u5f97\u82cd\u767d\u65e0\u529b\u3002\n\n\u5730\u7f18\u653f\u6cbb\u5f71\u54cd\uff1a\u5370\u5df4\u51b2\u7a81\u7684\u957f\u671f\u9690\u60a3\n\n\u6b64\u6b21\u7a7a\u6218\u4e0d\u4ec5\u662f\u4e24\u56fd\u519b\u4e8b\u5bf9\u6297\u7684\u5ef6\u7eed\uff0c\u4e5f\u53cd\u6620\u4e86\u5357\u4e9a\u5730\u533a\u7684\u5730\u7f18\u653f\u6cbb\u7d27\u5f20\u5c40\u52bf\u3002\u5370\u5ea6\u8fd1\u5e74\u6765\u52a0\u5927\u4e86\u519b\u5907\u91c7\u8d2d\u529b\u5ea6\uff0c\u5c24\u5176\u662f\u4ece\u6cd5\u56fd\u5f15\u8fdb\"\u9635\u98ce\"\u6218\u673a\uff0c\u8bd5\u56fe\u5728\u7a7a\u519b\u5b9e\u529b\u4e0a\u8d85\u8d8a\u5df4\u57fa\u65af\u5766\u3002\u800c\u5df4\u57fa\u65af\u5766\u5219\u901a\u8fc7\u4e0e\u4e2d\u56fd\u7684\u519b\u4e8b\u5408\u4f5c\uff0c\u8fdb\u4e00\u6b65\u63d0\u5347\u5176\u7a7a\u519b\u6280\u672f\u6c34\u5e73\u3002\n\n\u672a\u6765\uff0c\u5370\u5df4\u51b2\u7a81\u53ef\u80fd\u7ee7\u7eed\u5347\u7ea7\uff0c\u8fd9\u4e0d\u4ec5\u5a01\u80c1\u4e24\u56fd\u81ea\u8eab\u5b89\u5168\uff0c\u4e5f\u5bf9\u6574\u4e2a\u5357\u4e9a\u5730\u533a\u7684\u7a33\u5b9a\u6784\u6210\u6311\u6218\u3002\u56fd\u9645\u793e\u4f1a\u9700\u8981\u5bc6\u5207\u5173\u6ce8\u8fd9\u4e00\u5c40\u52bf\uff0c\u63a8\u52a8\u4e24\u56fd\u901a\u8fc7\u5916\u4ea4\u9014\u5f84\u89e3\u51b3\u4e89\u7aef\u3002\n\n\u7ed3\u8bed\n\n\u6b64\u6b21\u5370\u5df4\u7a7a\u6218\u7684\u771f\u76f8\u6216\u8bb8\u9700\u8981\u66f4\u591a\u65f6\u95f4\u624d\u80fd\u5b8c\u5168\u63ed\u5f00\u3002\u4f46\u53ef\u4ee5\u786e\u5b9a\u7684\u662f\uff0c\u73b0\u4ee3\u7a7a\u6218\u4e0d\u4ec5\u662f\u6280\u672f\u4e0e\u6218\u672f\u7684\u5bf9\u51b3\uff0c\u66f4\u662f\u4fe1\u606f\u4e0e\u8206\u8bba\u7684\u8f83\u91cf\u3002\u5370\u5ea6\u5728\u6b64\u6b21\u4e8b\u4ef6\u4e2d\u7684\u8868\u73b0\u66b4\u9732\u4e86\u5176\u5728\u519b\u4e8b\u6280\u672f\u548c\u8206\u8bba\u6218\u4e2d\u7684\u77ed\u677f\u3002\u800c\u5df4\u57fa\u65af\u5766\u5219\u901a\u8fc7\u7cbe\u51c6\u6253\u51fb\u548c\u6709\u6548\u5ba3\u4f20\uff0c\u5c55\u793a\u4e86\u5176\u7a7a\u519b\u7684\u5f3a\u5927\u5b9e\u529b\u3002\n\n\u5bf9\u4e8e\u5370\u5df4\u4e24\u56fd\u800c\u8a00\uff0c\u957f\u671f\u7684\u519b\u4e8b\u5bf9\u6297\u4e0d\u4ec5\u6d88\u8017\u4e86\u5927\u91cf\u8d44\u6e90\uff0c\u4e5f\u4f7f\u4e24\u56fd\u5173\u7cfb\u9677\u5165\u50f5\u5c40\u3002\u5982\u4f55\u63a8\u52a8\u4e24\u56fd\u8d70\u5411\u548c\u5e73\uff0c\u800c\u975e\u7ee7\u7eed\u9677\u5165\u65e0\u4f11\u6b62\u7684\u51b2\u7a81\uff0c\u624d\u662f\u56fd\u9645\u793e\u4f1a\u9700\u8981\u89e3\u51b3\u7684\u95ee\u9898\u3002",
        "source": {
          "uri": "m.163.com",
          "dataType": "news",
          "title": "m.163.com"
        },
        "authors": [],
        "image": "https://nimg.ws.126.net/?url=http%3A%2F%2Fdingyue.ws.126.net%2F2025%2F0510%2Fe8c63b52j00sw1oxm000ed000go008ug.jpg&thumbnail=750x2147483647&quality=75&type=jpg",
        "eventUri": "eng-10592421",
        "sentiment": null,
        "wgt": 484580617,
        "relevance": 3
      },
      {
        "uri": "8672500233",
        "lang": "eng",
        "isDuplicate": true,
        "date": "2025-05-10",
        "time": "13:42:07",
        "dateTime": "2025-05-10T13:42:07Z",
        "dateTimePub": "2025-05-10T13:39:06Z",
        "dataType": "news",
        "sim": 0,
        "url": "https://dnyuz.com/2025/05/10/experts-call-kennedys-plan-to-find-autisms-cause-unrealistic/",
        "title": "Experts call Kennedy's plan to find autism's cause unrealistic",
        "body": "WASHINGTON (AP) -- For many experts, Health Secretary Robert F. Kennedy Jr. 's promise for \"pulling back the curtain\" to find autism's causes in a few months is jarring -- and unrealistic.\n\nThat's because it appears to ignore decades of science linking about 200 genes that play a role -- and the quest to understand differences inside the brain that can be present at birth.\n\n\"Virtually all the evidence in the field suggests whatever the causes of autism -- and there's going to be multiple causes, it's not going to be a single cause -- they all affect how the fetal brain develops,\" said longtime autism researcher David Amaral of the UC Davis MIND Institute.\n\n\"Even though we may not see the behaviors associated with autism until a child is 2 or 3 years old, the biological changes have already taken place,\" he said.\n\nKennedy on Wednesday announced the National Institutes of Health would create a new database \"to uncover the root causes of autism and other chronic diseases\" by merging Medicaid and Medicare insurance claims with electronic medical records and other data. He has cited rising autism rates as evidence of an epidemic of a \"preventable disease\" caused by some sort of environmental exposure and has promised \"some of the answers by September.\"\n\nWhat is autism?\n\nAutism isn't considered a disease. It's a complex brain disorder better known as autism spectrum disorder, to reflect that it affects different people in different ways.\n\nSymptoms vary widely. For some people, profound autism means being nonverbal and having significant intellectual disabilities. Others have far milder effects, such as difficulty with social and emotional skills.\n\nAutism rates are rising -- not among profound cases but milder ones, said autism expert Helen Tager-Flusberg of Boston University.\n\nThat's because doctors gradually learned that milder symptoms were part of autism's spectrum, leading to changes in the late 1990s and early 2000s in diagnosis guidelines and qualifications for educational services, she said.\n\nWhat's the state of autism research?\n\nThe link between genes and autism dates back to studies of twins decades ago. Some are rare genetic variants passed from parent to child, even if the parent shows no signs of autism.\n\nBut that's not the only kind. As the brain develops, rapidly dividing cells make mistakes that can lead to mutations in only one type of cell or one part of the brain, Amaral explained.\n\nNoninvasive testing can spot differences in brain activity patterns in babies who won't be diagnosed with autism until far later, when symptoms become apparent, he said.\n\nThose kinds of changes stem from alterations in brain structure or its neural circuitry -- and understanding them requires studying brain tissue that's available only after death, said Amaral, who's the scientific director of a brain banking collaborative called Autism BrainNet. The bank, funded by the nonprofit Simons Foundation, has collected more than 400 donated brains, about half from people with autism and the rest for comparison.\n\nWhat about environmental effects?\n\nResearchers have identified other factors that can interact with genetic vulnerability to increase the risk of autism. They include the age of a child's father, whether the mother had certain health problems during pregnancy including diabetes, use of certain medications during pregnancy, and preterm birth.\n\nAny concern that measles vaccinations could be linked to autism has been long debunked, stressed Tager-Flusberg, who leads a new Coalition of Autism Scientists pushing back on administration misstatements about the condition.\n\nWhat about Kennedy's database plan?\n\nThe U.S., with its fragmented health care system, will never have the kind of detailed medical tracking available in countries like Denmark and Norway -- places with national health systems where research shows similar rises in autism diagnoses and no environmental smoking gun.\n\nExperts say Kennedy's planned database isn't appropriate to uncover autism's causes in part because there's no information about genetics.\n\nBut researchers have long used insurance claims and similar data to study other important questions, such as access to autism services. And the NIH described the upcoming database as useful for studies focusing on access to care, treatment effectiveness and other trends.\n\n___\n\nThe Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.",
        "source": {
          "uri": "dnyuz.com",
          "dataType": "news",
          "title": "DNyuz"
        },
        "authors": [],
        "image": "https://dnyuz.com/wp-content/uploads/2025/05/Experts-call-Kennedys-plan-to-find-autisms-cause-unrealistic.jpg",
        "eventUri": null,
        "sentiment": 0.05882352941176472,
        "wgt": 484580527,
        "relevance": 1
      },
      {
        "uri": "8672502221",
        "lang": "eng",
        "isDuplicate": false,
        "date": "2025-05-10",
        "time": "13:41:55",
        "dateTime": "2025-05-10T13:41:55Z",
        "dateTimePub": "2025-05-10T00:00:00Z",
        "dataType": "news",
        "sim": 0,
        "url": "https://www.nature.com/articles/s41398-025-03372-w",
        "title": "Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort study - Translational Psychiatry",
        "body": "First, we used cross-sectional and longitudinal non-genetic analysis to examine the association between circulating levels of CRP and depression/cognitive performance. Second, we conducted genetic risk score (GRS) and MR analysis to test whether genetic variants regulating levels and activity of CRP, IL-6, and GlycA were causally related with depression/cognitive performance. We also conducted the above analyses on closely related constructs (e.g., anxiety, negative/positive affect), for which associations with inflammation have previously been observed [47,48,49,50,51,52] but for which considerably less empirical data has been published. We hypothesized that higher levels of both circulating CRP levels and genetically predicted inflammatory biomarkers (i.e., CRP, IL-6, sIL-6R, and GlycA) would be associated with more severe depressive and anxious symptoms, higher levels of negative affect, and worse cognitive task performance.\n\nLifelines is a multi-disciplinary prospective population-based cohort study examining in a unique three-generation design the health and health-related behaviors of 167,729 persons living in the North of the Netherlands. It employs a broad range of investigative procedures in assessing the biomedical, socio-demographic, behavioral, physical and psychological factors which contribute to the health and disease of the general population, with a special focus on multi-morbidity and complex genetics [53]. This cohort has previously been described in detail [53] and further information on the types of data collected (https://data-catalogue.lifelines.nl/) and when assessment occurred (https://wiki.lifelines.nl/doku.php?id=general_assessments) are available online. In brief, both the baseline and follow-up visits were divided into two parts occurring two weeks apart. For both baseline and follow-up visits, diagnostic interviewing and cognitive assessment occurred in the first part and blood draw occurred in the second part two weeks later. The follow-up assessment occurred, on average, 3.91 years later (SD\u2009=\u20091.23).\n\nIn brief, participants were recruited via their general practitioner (49%), participating family members (38%), and self-registration on the Lifelines website (13%). Exclusion criteria for recruitment through the general practitioner included: insufficient knowledge of Dutch language, severe psychiatric or physical illness, limited life expectancy (\u2009<\u20095 years). Baseline data included approximately: 140,000 adults (18-65 years), 15,000 children (0-17 years), 12,000 elderly individuals (65+ years). Following baseline assessment, participants are invited to complete an in-person study visit every 5 years. Phenotypic and genotypic data are collected by Lifelines to permit investigation on determinants of health. Data for the current study were drawn from 147,815 individuals who were aged 18+ years at baseline and who did not report a diagnosis that typically impairs cognitive function, specifically Alzheimer's disease, other dementias, epilepsy, multiple sclerosis, Parkinson's disease, and stroke. In the non-genetic analyses, the analytic sample is smaller as CRP was assessed in a sub-sample of individuals (N\u2009=\u200955,098) as was baseline cognitive performance on the Ruff Figural Fluency Test (N\u2009=\u200988,096). The analytic sample is smaller for non-genetic (N\u2009\u2264\u200955,098), GRS (N\u2009\u2264\u200957,946) and MR (N\u2009\u2264\u200923,268) analysis as only a subset of participants who met inclusion criteria had outcome data and CRP data (non-genetic analysis), genetic data (GRS), or genetic and CRP data (MR) due to time and cost constraints. Phenotypic data were drawn from both the baseline assessment and the first follow-up assessment; whether a specific measure was assessed at baseline, first follow-up or both assessments is noted for each measure.\n\nThe Lifelines study was approved by the ethics committee of the University Medical Center Groningen, document number METC UMCG METc 2007/152. Informed consent was obtained from all individuals included in the study. All methods were performed in accordance with relevant guidelines and regulations.\n\nThe Ruff Figural Fluency Test (RFFT) is a reliable and valid measure of figural fluency, a dimension of executive function [54]. Participants were asked to draw as many unique designs as possible within 60\u2009s by connecting dots in different patterns. The task is composed of five parts, with each part containing 35 identical five-dot patterns (with or without distractors). The total number of unique designs was used as the dependent variable in the analyses, consistent with previous studies [55]. In Lifelines, the RFFT was administered to all participants until April 2012, and subsequently in a random half of the sample. Data from participants who failed to generate a single unique design per trial (n\u2009=\u2009181) were deemed invalid and removed.\n\nThe Cogstate Test Battery took approximately 10-15\u2009min to complete and consisted of four tasks: detection task (psychomotor speed), identification task (attention), one-back task (working memory), and one card learning task (episodic memory). For each task, outcomes recommended by Cogstate were selected, specifically: log10 transformed response time in millisecond (detection/identification tasks) and arcsine-transformed response accuracy (one-back/one card learning tasks). For the detection and identification tasks, higher values reflect poorer performance and for the one-back and one card learning tasks, higher values equal better performance. Data cleaning involved excluding participants with a high number of errors. The percentage of successful trials per Cogstate task was high, averaging 66% (n\u2009=\u200985,050; SD\u2009=\u20090.11) on the episodic memory task, 91% (n\u2009=\u200985,053; SD\u2009=\u20090.17) on the visual attention task, 92% (n\u2009=\u200985,053; SD\u2009=\u20090.20) on the psychomotor speed task, and 90% (n\u2009=\u200985,051; SD\u2009=\u20090.15) on the working memory task. A small number of participants exhibiting implausibly low accuracy rates indicative of poor effort, failure to comprehend task instructions, or technical errors were excluded from analyses. Specifically individuals with an accuracy rate less than: 25% on the episodic memory task (n\u2009=\u2009231), 40% on the visual attention task (n\u2009=\u20092,878), 45% on the psychomotor speed task (n\u2009=\u20093,914), and 35% on the working memory task (n\u2009=\u20091,330). For more details on the Cogstate Test Battery, see Supplementary Methods 1.1.\n\nThe Mini International Neuropsychiatric Interview - Simplified (MINI) is a reliable, valid, and brief structured interview that was designed to screen for psychiatric disorders [56,57,58]. Lifelines used an adapted version of a Dutch translation of the MINI that was administered by trained interviewers at baseline and self-administered on location at follow-up - details on the version used in Lifelines have previously been published [59]. Participants were considered to meet criteria for any depressive disorder if they met the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria for Major Depressive Disorder (MDD) or dysthymia at the time of the interview. Impairment was assessed in the MINI for dysthymia but not depression and consequently, impairment was not used as a criterion for MDD. Any anxiety disorder refers to meeting current criteria for any one of the following conditions that was assessed using the MINI: panic disorder, agoraphobia, social phobia, or Generalized Anxiety Disorder (GAD). We used four diagnostic groups as outcome variables: MDD, any depressive disorder, GAD, and any anxiety disorder.\n\nThe Positive and Negative Affect Schedule (PANAS) assesses positive and negative affect [60] using two 10-item subscales (examples of items include 'excited' on positive subscale; 'upset' on negative subscale). Participants are asked to rate the extent that they experienced each item during the last four weeks on a five-point scale (ranging from 'not at all' to 'extremely'). The outcome is the summed score on each subscale, which ranges from 10 to 50 (higher value reflects higher positive or negative affect, respectively). The PANAS has been shown to be reliable and valid [61]. Reliability, as estimated using Cronbach's alpha, for the positive subscale of the PANAS at baseline was 0.79 and 0.84 for the negative subscale.\n\nParticipants gave blood samples before 10AM via venipuncture following an overnight fast. Complete details on blood specimen data collection have previously been reported [53, 55]. Due to assay costs, CRP was assessed in approximately 35% of Lifelines participants and data were available for 55,098 individuals in the analytic sample. CRP was quantified using three separate methods over the course of baseline assessment (Method 1: 12.90% of total CRP values assessed in serum; CardioPhase hsCRP; Method 2: 84.58% of total CRP values, assessed in plasma; CardioPhase high sensitivity (hs)CRP, Siemens Healthcare Diagnostics, Marburg, Germany; Method 3: 2.52% of total CRP values; assessed in plasma; CRPL3, Roche Diagnostics, Mannheim, Germany). Assay methods 2 and 3 were identical and only differed in terms of the manufacturer. A conversion formula (new\u2009=\u20090.92 x old - 0.01) was derived from an internal validation using 39 samples, according to the AMC (alternative method comparison, Deming Regression) protocol in order that Method 1 could be compared with Method 2 and 3 [55]. For CardioPhase hsCRP, the intra-assay coefficient of variability was 3.45% and the inter-assay coefficient of variability was 3.15%. For CRPL3, the intra-assay coefficient of variability was 4.15% and the inter-assay coefficient of variability was 5.8%.\n\nGenotype data were available for a subgroup of participants in Lifelines. Genotyping was conducted using three chip arrays: Illumina CytoSNP-12 Bead Chip v2 array (N\u2009=\u200917,033), Infinium Global Screening Array (GSA) Beadchip-24 v1.0 (N\u2009=\u200938,030), FinnGen Thermo Fisher Axiom \u00ae custom array (Affymetrix; N\u2009=\u200929,166). For details on quality checks (QC's) and imputation conducted by Lifelines, see Supplementary Methods 1.2. Following Lifelines QC's, the total sample size for participants who met criteria for this study: CytoSNP (N\u2009=\u200914,942), GSA (N\u2009=\u200931,810) and Affymetrix (N\u2009=\u200926,334). We applied additional QC's which included removing: one of the duplicates (individuals who were genotyped on more than one chip) and first-degree relatives between chips, non-European individuals (identified by Lifelines), and genetic outliers (identified by Lifelines); see Supplementary Figure 2 for more details. This resulted in a total of 58,713 participants with genetics data included in this study (CytoSNP N\u2009=\u20097,632; GSA N\u2009=\u200924,975; Affymetrix N\u2009=\u200926,106). For more details on the genetic data in Lifelines, see Supplementary Methods 1.2.\n\nCovariates included age, sex, educational attainment, body mass index (BMI) and health status. Age, sex, and educational attainment were self-reported by participants. Educational attainment was determined using a single-item question and was categorized by Lifelines as: low [no education, primary education, lower/preparatory vocational education, lower general secondary education (leaving secondary school aged >16 years)], moderate (intermediate vocational education/apprenticeship, higher secondary education), and high (higher vocational education, university). We recoded educational attainment so that higher values represent lower educational attainment. To estimate body mass index (BMI), height was measured to the closest 0.1\u2009cm and body weight was measured without shoes to 0.1\u2009kg precision. For health status, a composite measure was created counting several self-reported chronic medical conditions related to increased levels of inflammation (i.e., arthritis, asthma, coeliac disease, Crohn's disease, diabetes, and psoriasis); we then categorized participants into those with no relevant chronic medical condition, 1, 2 or 3+ conditions.\n\nAnalyses were conducted in R version 4.1.1.\n\nMultivariable linear and logistic regression models were estimated using base functions in R (i.e., 'lm', 'glm'). Assumptions underpinning regression analyses were investigated using 'broom' and 'ggfortify' packages [62]. Models using CRP on its naturally occurring scale (mg/L in this study) demonstrated deviations in the assumptions of (i) a linear relationship between the predictor and outcome variables and (ii) homogeneity of variance of the residuals that were all substantially improved when CRP was log-transformed; thus, CRP was transformed by natural log for all analyses.\n\nGenetic risk scores (GRS) were calculated to determine whether GRS for inflammatory markers (CRP, IL-6, IL-6R, sIL-6R, GlycA) were associated with depression/anxiety, affect and cognitive outcomes. To create GRS for each inflammatory marker, we identified genetic variants (single nucleotide polymorphisms [SNPs]) associated with these proteins in large available GWAS or using SNP lists from previous publications, see Supplementary Table 1. For details on the GWAS used and accessing summary statistics, please see Supplementary Methods 1.3 and Supplementary Tables 2, 3. The following criteria were used to identify SNPs from GWAS for each inflammatory marker: p-value\u2009<\u20095\u2009\u00d7\u200910, linkage disequilibrium clumping (r\u2009=\u20090.01, kb\u2009=\u20091000 based on the European-clustering individuals in the 1000 genomes reference panel) using ld_clump() [63] in the ieugwasr package, minor allele frequency >0.01. In the primary analysis, we restricted the SNP set to cis variants (SNPs\u2009+/-1Mb from protein coding gene based on Genome Reference Consortium Human Build used in the GWAS) [64,65,66]. The reason for restricting to cis variants in the primary analysis is because, due to their proximity to the protein coding gene, they are more likely to be valid instruments, as they are more likely to influence mRNA expression and protein levels (thus being less pleiotropic) [67]. For GlycA, which does not have a single coding gene due to its composite nature, we used the largest available GWAS in our primary analysis. In our secondary analyses, we used both cis and trans variants from GWAS (i.e., we did not restrict to cis variants). Each SNP list was used to create a weighted GRS for each Lifelines participant. Specifically, the risk alleles were weighted by the effect size (beta) reported in the GWAS/previous study and then summed to provide a risk score. Any SNP identified in GWAS/previous study that was not available in Lifelines was replaced with a proxy (where possible) that had r\u2009>\u20090.8 (using LDproxy_batch function in EUR population in R), rsID (SNP name) available, SNP available in full summary statistic GWAS, and in Lifelines [68, 69]. GRS were created in Plink v1.90 [70] and continuous phenotypes were standardized within each chip (z-scored) for direct comparison (CRP levels were log transformed but not standardized). To adjust for relatedness within each chip, two approaches were taken. The primary approach applied the GRAMMAR method [71] and the secondary approach involved re-running analyses removing close relatives (up to first-degree, up to second-degree, and up to third-degree), see Supplementary Materials 1.4 and 1.5 for details. We then ran regression models predicting each outcome using the standardized GRS, including top 10 genetic PCs (calculated on merged Lifelines genotype data), age, sex, and chip. Maximum sample size for analyses: no relatives within chips removed (N\u2009=\u200958,713), up to first-degree removed (N\u2009=\u200950,955), up to second-degree removed (N\u2009=\u200950,255), up to third-degree removed (N\u2009=\u200948,880). Unadjusted analyses are also reported in the Supplementary Tables 6 and 7.\n\nTo conduct MR using individual level data and two-stage least squares regression, genetic data, exposure data, and outcome data are required. As only CRP is available within the Lifelines cohort (IL-6 and GlycA are not currently available), only this inflammatory marker could be assessed in the MR analysis. Where there was evidence of associations between CRP GRS and outcomes, we followed this up with MR to assess potential causality. Two-stage least squares regressions were conducted using the AER package [72]. Analyses were GRAMMAR adjusted for relatedness and all regression models adjusted for age, sex, and chip. Three assumptions are necessary for valid inferences from MR: (i) the genetic variants are robustly associated with the exposure, (ii) there is no confounding of the genetic variants and the outcome and (iii) the genetic variants are independent of the outcome given the exposure. Only the first assumption can be formally tested (typically using the F-statistic of the association between the genetic instrument and the exposure). Whilst the other two assumptions cannot be proven to be true, they can be disproven [73]. Please see for a primer on MR [73]. To test the first MR assumption, we ran linear regressions to check whether CRP GRS were associated with circulating CRP levels in participants with both genetic and CRP data available (n\u2009=\u200923,607) using the GRAMMAR method. We also checked whether any inflammatory marker GRS were associated with potential confounders (BMI, current smoking status, educational attainment; all models were adjusted for age, sex, and chip).",
        "source": {
          "uri": "nature.com",
          "dataType": "news",
          "title": "Nature"
        },
        "authors": [],
        "image": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-025-03372-w/MediaObjects/41398_2025_3372_Fig1_HTML.png",
        "eventUri": null,
        "sentiment": -0.1294117647058823,
        "wgt": 484580515,
        "relevance": 1
      }
    ],
    "totalResults": 190335,
    "page": 1,
    "count": 5,
    "pages": 38067
  }
}